INVESTORS MEDIA Physician Login Register for Updates Contact Us Share+ COMPANY VIDEO CENTER SCIENCE ONCOTYPE DX® DATA CAREERS Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions. Oncotype DX for DCIS DCIS / Stage 0 breast cancer affects 1 out of every 5 women diagnosed with breast cancer in the U.S. Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Learn more about the Oncotype DX test for DCIS. VideoCenter Oncotype DX - 10 Years & Beyond Over the past decade, we have redefined personalized medicine through the innovation of Oncotype DX, making genomics an indispensable part of breast, colon and prostate cancer diagnosis and treatment. Learn more about our next decade and how we are continuing to use genomic information to make cancer care smarter. PRESS RELEASES September 29, 2014 Genomic Health Announces Positive Results from Latest Clinical Validation Study of Oncotype DX® as Predictor of Near... September 26, 2014 Genomic Health Announces Oral Presentation of Positive Results from Second Large, Independent Clinical Validation St... All press releases Home Glossary Site Map Licenses Legal Privacy Policy Terms & Conditions Copyright © 2004-2021 Genomic Health, Inc. All rights reserved.